LAWFUEL – Press Release Service – International legal practice Norton Rose is advising Hoare Govett Limited, nominated adviser, broker and underwriter, on the cash placing recently announced by Osmetech PLC. Simultaneous with the placing, Osmetech announced a private placement with a US-based biotech fund. The placing and the private placement will raise gross proceeds of approximately £12.8 million.
The placing is conditional on the private placement as well as the approval of Osmetech’s shareholders. Admission of the new ordinary shares to be issued in connection with the placing and private placement is anticipated to take place on 11 July 2006.
Osmetech is an international diagnostics business serving the high growth near patient test market and targeting small to medium sized hospitals. The funds raised will be used for general working capital purposes, including the funding of current operations and new product launches.
Norton Rose was led by corporate finance partner Paul Whitelock, assisted by Kate Hargreaves and Kathy MacDonald with US law advice provided by Tom Vita. Ashurst advised Osmetech.
For further information please contact:
Sean Twomey, head of public relations
+44(0)20 7444 3740 [email protected]
Notes for editors:
Norton Rose is a leading international legal practice. We offer a full business law service from our offices across Europe, the Middle East and Asia.
Knowing how our clients’ businesses work and understanding what drives their industries is fundamental to us. Our lawyers share industry knowledge and sector-specific expertise across borders, enabling us to support our clients anywhere in the world. We are strong in corporate finance; financial institutions; energy and infrastructure (including real estate); transport; and technology.
We have the resources to deliver 1,000 lawyers across our offices in Amsterdam, Athens, Bahrain, Bangkok, Beijing, Brussels, Dubai, Frankfurt, Hong Kong, Jakarta*, London, Milan, Moscow, Munich, Paris, Piraeus, Prague, Rome, Shanghai, Singapore and Warsaw.
More detailed information is available on our website at: www.nortonrose.com
* associate office
The contents of this e-mail are confidential to the ordinary user of
the e-mail address to which it was addressed and may also be
privileged. If you are not the addressee of this e-mail you may not
copy, forward, disclose or otherwise use it or any part of it in any
form whatsoever. If you have received this e-mail in error please
e-mail the sender by replying to this message.
A list of the partners of Norton Rose, Solicitors, can be inspected at
Please refer to www.nortonrose.com/regulation for the firm’s regulatory position.